Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Osage Venture Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Osage Venture Partners

Osage Venture Partners

Operating

Osage Venture Partners: A US-based brokerage firm specializing in healthcare and tech venture capital.

Location
Bala Cynwyd, PA, US
Founded
1990
Firm
Compare
Portfolio
Employees
Website

Osage Venture Partners (OVP) is a US-based venture capital firm specializing in early-stage B2B software startups, particularly those driving innovation in work and education. The firm typically invests in Seed and Series A rounds, with occasional participation in later stages. OVP focuses on sectors such as healthcare and technology, leveraging its two decades of experience to identify and support disruptive innovations.

Notable portfolio companies include Ambiq Micro, Aptinyx, and ArsenalBio, reflecting OVP's commitment to high-impact ventures. The firm is led by experienced partners who bring a wealth of knowledge and industry connections to the table. OVP's investment philosophy emphasizes the importance of market, technology, and business models, but places a strong focus on the entrepreneurial teams behind the startups. Additionally, OVP offers unique value-add services, including strategic guidance and operational support, to help portfolio companies achieve their growth potential.

Osage Venture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments192
Current Portfolio Count102
Total Portfolio Exits7

Top Investment Stages

Series A82 (46.9%)
Series B38 (21.7%)
Seed22 (12.6%)
Series C17 (9.7%)
Series Unknown16 (9.1%)

Stage Mix

Series A 47%Series B 22%Seed 13%Series C 10%Series Unknown 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Arcanna.ai logo

Arcanna.ai

Verve logo

Verve

Precede Biosciences logo

Precede Biosciences

ReCode Therapeutics logo

ReCode Therapeutics

Kate Therapeutics logo

Kate Therapeutics

Incentivio logo

Incentivio

DeepHow logo

DeepHow

Fount Global logo

Fount Global

Chroma Medicine logo

Chroma Medicine

Escient Pharmaceuticals logo

Escient Pharmaceuticals

Curavit Clinical Research logo

Curavit Clinical Research

Normunity logo

Normunity

Metalenz logo

Metalenz

Connectbase logo

Connectbase

Delfi Diagnostics logo

Delfi Diagnostics

Trinsic logo

Trinsic

AssetWatch logo

AssetWatch

MicroTransponder logo

MicroTransponder

Tellie logo

Tellie

Brimstone logo

Brimstone

DeepSurface Security logo

DeepSurface Security

Circonus logo

Circonus

Antiva Biosciences logo

Antiva Biosciences

Transeo logo

Transeo

Malbek logo

Malbek

Osage Venture Partners - Classification

Also Known As
  • RA Bench Securities, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end